Highlights and Quick Summary
- EPS (Diluted) for the quarter ending September 30, 2022 was -1.56 (a 52.94% increase compared to previous quarter)
- Year-over-year quarterly EPS (Diluted) increased by 64.21%
- Annual EPS (Diluted) for 2021 was -5.77 (a 37.71% increase from previous year)
- Annual EPS (Diluted) for 2020 was -4.19 (a 136.72% increase from previous year)
- Annual EPS (Diluted) for 2019 was -1.77 (a -22.71% decrease from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Diluted) of Beam Therapeutics Inc.
Most recent EPS (Diluted)of BEAM including historical data for past 10 years.Interactive Chart of EPS (Diluted) of Beam Therapeutics Inc.
Beam Therapeutics Inc. EPS (Diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -1.56 | -1.02 | -1.01 | – |
| 2021 | -0.95 | -0.42 | -1.23 | -3.35 | -5.77 |
| 2020 | -1.69 | -0.69 | -0.69 | -1.03 | -4.19 |
| 2019 | – | – | – | -0.61 | -1.77 |
| 2018 | – | – | – | – | -2.29 |
| 2017 | – | – | – | – | -0.19 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology